Cross-Border Impact Ventures
Finance · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Mars Centre - Phase 2, 661 University Av...Website
crossborder.venturesRevenue
<$5 MillionIndustry
About Cross-Border Impact Ventures
Cross-Border Impact Ventures is an impact venture capital firm focused on investing in transformative health technology companies that address significant global markets in women, children, and adolescent health. The firm seeks to support companies that are commercializing medical devices, diagnostics, therapeutics, and digital health innovations, prioritizing sectors such as sexual and reproductive health and maternal and child health. With a commitment to gender health equality, they aim to achieve both positive social impact and financial returns. Cross-Border Impact Ventures provides hands-on support to management teams, facilitating access to new markets and capital in North America, Europe, and beyond.Explore more
SIC Code 61,615NAICS Code 52,523Show moreCross-Border Impact Ventures Org Chart
Compare Similar Companies to Cross-Border Impact Ventures
Compare insights from companies similar to Cross-Border Impact Ventures, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Cross-Border Impact Ventures Tech Stack
A closer look at the technologies used by Cross-Border Impact Ventures
Top Finance Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Cross-Border Impact Ventures
Sign Up For FreeTo access detailed company insights
Cross-Border Impact Ventures is an impact venture capital firm focused on investing in transformative health technology companies that address significant global markets in women, children, and adolescent health. The firm seeks to support companies that are commercializing medical devices, diagnostics, therapeutics, and digital health innovations,... Read More
